Click it and Unblock the Notifications
Latest Updates
-
Diwali 2026: Chakli To Nimki, 7 Regional Savoury Snacks That Bring Traditional Indian Flavours To Your Table -
Filmmaker Sanjay Gupta Passes Away At 57: ‘Aatish’ To ‘Kaabil’, Look At His Three-Decade Bollywood Journey -
Halloween 2026: From Chudail To Yakshi, 5 Mysterious Supernatural Beings That Haunt Indian Folklore -
Rashtriya Ekta Diwas 2026: Significance, History And Sardar Vallabhbhai Patel's Role In Uniting India -
Survey Finds 68% Of Previously Married Singles Hesitate To Match With Never-Married Partners -
Diwali 2026: Complete Five-Day Festival Calendar, Dates, Significance And Celebrations -
Weight, Alcohol, Hormones: Pathologist Shares Insights On What Really Shapes A Woman’s Breast Cancer Risk -
Diwali 2026: 5 Healthy Homemade Indian Sweets That Go Beyond Traditional Mithai -
Stroke In Young Women: Neurologist Explains Warning Signs And Hormonal Risk Factors -
‘Star Trek’ And ‘X-Men’ Actor Patrick Stewart Passes Away At 86 After Dementia Battle
Childhood Cancer Treatment May Affect Short-Term Memory
Children exposed to cancer treatment such as chemotherapy are likely to have decreased cognitive flexibility and a weaker short-term memory, researchers say.
Children exposed to cancer treatment such as chemotherapy are likely to have decreased cognitive flexibility and a weaker short-term memory, researchers say.
The results show that cognitive functions which are slow developing or mature during adolescence -- in particular short-term memory -- are very vulnerable to the chemotherapy treatment.
However, cognitive functions such as long-term memory and the ability to concentrate remain largely unaffected as they develop before the treatment.
"Tests that require quick switching between tasks or remembering new information for a short amount of time were clearly more difficult for former cancer patients. The developmental stage of the brain at the start of the cancer treatment probably plays a decisive role," Rudi D'Hooge, Professor at the University of Leuven in Belgium.
For the study, the team examined 31 young adults who underwent chemotherapy as a child, on average around the age of six and a half.
The survivors' performance was compared on a number of psychological tests with the results of a control group.
Further, analysing phosphorylated Tau (p-Tau) -- a protein which is part of the internal structure of our nerve cells -- the researchers found that high concentrations of p-Tau predict cognitive problems at a later age.
"If we systematically measure these p-Tau levels in the future, we can offer specific help to children with high values. With early coaching aimed at the most relevant functions we can prevent problems that would otherwise manifest 10 to 15 years after the treatment," Iris Elens, a psychiatrist at the University of Leuven.
With Inputs From IANS
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.
Continue with Google
